The Landmark Series: Neoadjuvant Therapy for Patients with Resectable Gastroesophageal Junction Adenocarcinomas
Crossref DOI link: https://doi.org/10.1245/s10434-026-20114-4
Published Online: 2026-07-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pettigrew, Morgan F.
Coburn, Natalie G.
Woo, Yanghee
Porembka, Matthew R.
Text and Data Mining valid from 2026-07-07
Version of Record valid from 2026-07-07
Article History
Received: 1 April 2026
Accepted: 18 June 2026
First Online: 7 July 2026
Disclosure
: Yanghee Woo - SAB for AstraZeneca.